467 related articles for article (PubMed ID: 27191662)
1. Low-dose versus high-dose heparin locks for hemodialysis catheters: a systematic review and meta-analysis.
Han X; Yang X; Huang B; Yuan L; Cao Y
Clin Nephrol; 2016 Jul; 86(7):1-8. PubMed ID: 27191662
[TBL] [Abstract][Full Text] [Related]
2. Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
Zhao Y; Li Z; Zhang L; Yang J; Yang Y; Tang Y; Fu P
Am J Kidney Dis; 2014 Mar; 63(3):479-90. PubMed ID: 24125729
[TBL] [Abstract][Full Text] [Related]
3. Citrate versus heparin lock for prevention of hemodialysis catheter-related complications: updated systematic review and meta-analysis of randomized controlled trials.
Mai H; Zhao Y; Salerno S; Li Y; Feng Y; Ma L; Fu P
Int Urol Nephrol; 2019 Jun; 51(6):1019-1033. PubMed ID: 31012037
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy and safety of lock solutions for the prevention of catheter-related complications including infectious and bleeding events in adult haemodialysis patients: a systematic review and network meta-analysis.
Sheng KX; Zhang P; Li JW; Cheng J; He YC; Böhlke M; Chen JH
Clin Microbiol Infect; 2020 May; 26(5):545-552. PubMed ID: 31857208
[TBL] [Abstract][Full Text] [Related]
5. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters.
Shah P; Shah V
Cochrane Database Syst Rev; 2005 Jul; (3):CD002772. PubMed ID: 16034876
[TBL] [Abstract][Full Text] [Related]
6. Sodium citrate 4% versus heparin as a lock solution in hemodialysis patients with central venous catheters.
Yon CK; Low CL
Am J Health Syst Pharm; 2013 Jan; 70(2):131-6. PubMed ID: 23292266
[TBL] [Abstract][Full Text] [Related]
7. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters.
Shah PS; Shah VS
Cochrane Database Syst Rev; 2008 Apr; (2):CD002772. PubMed ID: 18425882
[TBL] [Abstract][Full Text] [Related]
8. Ethanol lock is effective on reducing the incidence of tunneled catheter-related bloodstream infections in hemodialysis patients: a systematic review and meta-analysis.
Zhao T; Liu H; Han J
Int Urol Nephrol; 2018 Sep; 50(9):1643-1652. PubMed ID: 29667048
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease.
Wang Y; Ivany JN; Perkovic V; Gallagher MP; Woodward M; Jardine MJ
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD009631. PubMed ID: 27039404
[TBL] [Abstract][Full Text] [Related]
10. Low dose heparin lock (1000 U/mL) maintains tunnelled hemodialysis catheter patency when compared with high dose heparin (5000 U/mL): A randomised controlled trial.
Chu G; Fogarty GM; Avis LF; Bergin S; McElduff P; Gillies AH; Choi P
Hemodial Int; 2016 Jul; 20(3):385-91. PubMed ID: 26833752
[TBL] [Abstract][Full Text] [Related]
11. Effect of ultra-low dose and standard heparin locks on early tunnelled dialysis catheter outcomes in low-risk dialysis patients.
Renaud CJ; Lim EK; Tho SJ; Yeoh LY
Nephrology (Carlton); 2015 Feb; 20(2):85-90. PubMed ID: 25346031
[TBL] [Abstract][Full Text] [Related]
12. Cathasept Line Lock and Microbial Colonization of Tunneled Hemodialysis Catheters: A Multicenter Randomized Controlled Trial.
Kanaa M; Wright MJ; Akbani H; Laboi P; Bhandari S; Sandoe JA
Am J Kidney Dis; 2015 Dec; 66(6):1015-23. PubMed ID: 26141306
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulant therapies for the prevention of intravascular catheters malfunction in patients undergoing haemodialysis: systematic review and meta-analysis of randomized, controlled trials.
Wang AY; Ivany JN; Perkovic V; Gallagher MP; Jardine MJ
Nephrol Dial Transplant; 2013 Nov; 28(11):2875-88. PubMed ID: 24169613
[TBL] [Abstract][Full Text] [Related]
14. Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults.
López-Briz E; Ruiz Garcia V; Cabello JB; Bort-Martí S; Carbonell Sanchis R; Burls A
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD008462. PubMed ID: 30058070
[TBL] [Abstract][Full Text] [Related]
15. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters.
Shah P; Shah V
Cochrane Database Syst Rev; 2001; (3):CD002772. PubMed ID: 11687025
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic and other lock treatments for tunnelled central venous catheter-related infections in children with cancer.
Schoot RA; van Dalen EC; van Ommen CH; van de Wetering MD
Cochrane Database Syst Rev; 2013 Jun; (6):CD008975. PubMed ID: 23799867
[TBL] [Abstract][Full Text] [Related]
17. Does antimicrobial lock solution reduce catheter-related infections in hemodialysis patients with central venous catheters? A Bayesian network meta-analysis.
Zhang J; Wang B; Li R; Ge L; Chen KH; Tian J
Int Urol Nephrol; 2017 Apr; 49(4):701-716. PubMed ID: 28035620
[TBL] [Abstract][Full Text] [Related]
18. Ethanol locks for the prevention of catheter-related infection in patients with central venous catheter: A systematic review and meta-analysis of randomized controlled trials.
Zhang J; Wang B; Wang J; Yang Q
PLoS One; 2019; 14(9):e0222408. PubMed ID: 31513652
[TBL] [Abstract][Full Text] [Related]
19. Comparison of heparin to citrate as a catheter locking solution for non-tunneled central venous hemodialysis catheters in patients requiring renal replacement therapy for acute renal failure (VERROU-REA study): study protocol for a randomized controlled trial.
Bruyère R; Soudry-Faure A; Capellier G; Binquet C; Nadji A; Torner S; Blasco G; Yannaraki M; Barbar SD; Quenot JP
Trials; 2014 Nov; 15():449. PubMed ID: 25409678
[TBL] [Abstract][Full Text] [Related]
20. Reevaluation of lock solutions for Central venous catheters in hemodialysis: a narrative review.
Wang Y; Sun X
Ren Fail; 2022 Dec; 44(1):1501-1518. PubMed ID: 36047812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
